-
Je něco špatně v tomto záznamu ?
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases
M. Vašáková, M. Šterclová, L. Kolesár, A. Slavčev, P. Pohunek, J. Šulc, J. Skibová, I. Stříž
Jazyk angličtina Země Velká Británie
Grantová podpora
NR9131
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 1997 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1972-01-01 do Před 1 rokem
Wiley Online Library (archiv)
od 1997-01-01 do 2012-12-31
Wiley Free Content
od 1997 do Před 1 rokem
- MeSH
- bronchoalveolární laváž MeSH
- bronchoalveolární lavážní tekutina cytologie imunologie MeSH
- cytokiny metabolismus MeSH
- financování organizované MeSH
- intersticiální plicní nemoci imunologie patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- počet buněk MeSH
- respirační funkční testy MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP) and sarcoidosis belong to interstitial lung diseases (ILD) where an imbalance of regulatory, profibrotic and antifibrotic cytokines is hypothesized. The relationship of bronchoalveolar lavage (BAL) fluid (BALF) cytokines, BALF cell profile and ILD course is supposed. The aim of our study was to correlate BALF cytokine and chemokine levels with BALF cellular characteristics and lung function parameters in different ILD. Twenty-two sarcoidosis, seven IPF and 11 HP patients underwent lung function tests and BAL. The BALF differential cell counts and superficial cell markers were characterized, and MCP-1, MIP-1alpha, MIP-1beta, RANTES, epithelial neutrophil-activating protein (ENA)-78, FGF, G-CSF, GM-CSF, IFN-gamma, interleukin (IL)-1alpha, IL-1RA, IL-1beta, -2beta, -4beta, -5beta, -6beta, -8beta, -10beta, -17beta, tumour necrosis factor (TNF)-alpha, thromobopoietin (Tpo) and vascular endothelial growth factor (VEGF) values measured. The BALF VEGF values were highest in sarcoidosis (P = 0.0526). IL-1RA values were higher in IPF and HP compared with sarcoidosis (P = 0.0334). IL-8/ENA-78 ratio positively correlated with BALF neutrophil counts in IPF (r = 0.89, P = 0.04). Vital capacity and TL(CO) values positively correlated with VEGF and negatively with IL-8 BALF levels in all ILDs but the correlations were most significant in sarcoidosis group. We suppose that VEGF plays a role in ILDs' early phases and has rather angiogenic than profibrotic effect. On the contrary, IL-8 is probably upregulated in advanced ILDs with prominent fibrosis and marked lung functions decline. We state that BALF VEGF, IL-8 and ENA-78 levels and IL-8/ENA-78 ratio could become useful markers of ILDs' phase, activity and prognosis. They might also be helpful in treatment modality choice.
Citace poskytuje Crossref.org
- 000
- 03569naa 2200433 a 4500
- 001
- bmc11009543
- 003
- CZ-PrNML
- 005
- 20221006145003.0
- 008
- 110510s2009 xxk e eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1365-3083.2008.02222.x $2 doi
- 035 __
- $a (PubMed)19281539
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Koziar Vašáková, Martina, $d 1964- $7 xx0104496
- 245 10
- $a Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases / $c M. Vašáková, M. Šterclová, L. Kolesár, A. Slavčev, P. Pohunek, J. Šulc, J. Skibová, I. Stříž
- 314 __
- $a Department of Respiratory Diseases, 1st Medical School, Charles University, University Thomayer Hospital Prague, Prague, Czech Republic. martina.vasakova@ftn.cz
- 520 9_
- $a Idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP) and sarcoidosis belong to interstitial lung diseases (ILD) where an imbalance of regulatory, profibrotic and antifibrotic cytokines is hypothesized. The relationship of bronchoalveolar lavage (BAL) fluid (BALF) cytokines, BALF cell profile and ILD course is supposed. The aim of our study was to correlate BALF cytokine and chemokine levels with BALF cellular characteristics and lung function parameters in different ILD. Twenty-two sarcoidosis, seven IPF and 11 HP patients underwent lung function tests and BAL. The BALF differential cell counts and superficial cell markers were characterized, and MCP-1, MIP-1alpha, MIP-1beta, RANTES, epithelial neutrophil-activating protein (ENA)-78, FGF, G-CSF, GM-CSF, IFN-gamma, interleukin (IL)-1alpha, IL-1RA, IL-1beta, -2beta, -4beta, -5beta, -6beta, -8beta, -10beta, -17beta, tumour necrosis factor (TNF)-alpha, thromobopoietin (Tpo) and vascular endothelial growth factor (VEGF) values measured. The BALF VEGF values were highest in sarcoidosis (P = 0.0526). IL-1RA values were higher in IPF and HP compared with sarcoidosis (P = 0.0334). IL-8/ENA-78 ratio positively correlated with BALF neutrophil counts in IPF (r = 0.89, P = 0.04). Vital capacity and TL(CO) values positively correlated with VEGF and negatively with IL-8 BALF levels in all ILDs but the correlations were most significant in sarcoidosis group. We suppose that VEGF plays a role in ILDs' early phases and has rather angiogenic than profibrotic effect. On the contrary, IL-8 is probably upregulated in advanced ILDs with prominent fibrosis and marked lung functions decline. We state that BALF VEGF, IL-8 and ENA-78 levels and IL-8/ENA-78 ratio could become useful markers of ILDs' phase, activity and prognosis. They might also be helpful in treatment modality choice.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a bronchoalveolární laváž $7 D018893
- 650 _2
- $a bronchoalveolární lavážní tekutina $x cytologie $x imunologie $7 D001992
- 650 _2
- $a počet buněk $7 D002452
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intersticiální plicní nemoci $x imunologie $x patologie $7 D017563
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a respirační funkční testy $7 D012129
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Šterclová, Martina, $d 1979- $7 xx0108032
- 700 1_
- $a Kolesár, Libor $7 xx0142511
- 700 1_
- $a Slavčev, Antonij $7 xx0060517
- 700 1_
- $a Pohunek, Petr, $d 1956- $7 jn99240000886
- 700 1_
- $a Šulc, Jan $7 xx0061770
- 700 1_
- $a Skibová, Jelena $7 xx0061183
- 700 1_
- $a Stříž, Ilja, $d 1958- $7 jn20000402309
- 773 0_
- $t Scandinavian Journal of Immunology $w MED00010600 $g Roč. 69, č. 3 (2009), s. 268-274
- 856 41
- $u https://doi.org/10.1111/j.1365-3083.2008.02222.x $y plný text volně přístupný
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110513110009 $b ABA008
- 991 __
- $a 20221006144957 $b ABA008
- 999 __
- $a ok $b bmc $g 839076 $s 702931
- BAS __
- $a 3
- BMC __
- $a 2009 $b 69 $c 3 $d 268-274 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
- GRA __
- $a NR9131 $p MZ0
- LZP __
- $a 2011-2B09/jvme